Confirmed responses deepened with an average maximum tumor reduction from baseline of 89% and median time on treatment increased to 19 months ...
Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation ...
A silent productivity killer is operating in every enterprise without detection, causing harm unnoticed: the 100-page slide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results